These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31177439)

  • 1. Intracellular Assays to Monitor Survival and Growth of Yersinia pestis Within Macrophages.
    Pulsifer AR; VanCleave TT; Lawrenz MB
    Methods Mol Biol; 2019; 2010():181-196. PubMed ID: 31177439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of bioluminescent bioreporters for in vitro and in vivo tracking of Yersinia pestis.
    Sun Y; Connor MG; Pennington JM; Lawrenz MB
    PLoS One; 2012; 7(10):e47123. PubMed ID: 23071730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Gentamicin Concentration and Exposure Time on Intracellular
    VanCleave TT; Pulsifer AR; Connor MG; Warawa JM; Lawrenz MB
    Front Cell Infect Microbiol; 2017; 7():505. PubMed ID: 29312891
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Connor MG; Pulsifer AR; Chung D; Rouchka EC; Ceresa BK; Lawrenz MB
    mBio; 2018 Feb; 9(1):. PubMed ID: 29463656
    [No Abstract]   [Full Text] [Related]  

  • 5. Yersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages.
    Spinner JL; Winfree S; Starr T; Shannon JG; Nair V; Steele-Mortimer O; Hinnebusch BJ
    J Leukoc Biol; 2014 Mar; 95(3):389-98. PubMed ID: 24227798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transposon site hybridization screen identifies galU and wecBC as important for survival of Yersinia pestis in murine macrophages.
    Klein KA; Fukuto HS; Pelletier M; Romanov G; Grabenstein JP; Palmer LE; Ernst R; Bliska JB
    J Bacteriol; 2012 Feb; 194(3):653-62. PubMed ID: 22139502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of
    Dudte SC; Hinnebusch BJ; Shannon JG
    Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
    [No Abstract]   [Full Text] [Related]  

  • 8. Yersinia pestis intracellular parasitism of macrophages from hosts exhibiting high and low severity of plague.
    Ponnusamy D; Clinkenbeard KD
    PLoS One; 2012; 7(7):e42211. PubMed ID: 22848745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.
    Lukaszewski RA; Kenny DJ; Taylor R; Rees DG; Hartley MG; Oyston PC
    Infect Immun; 2005 Nov; 73(11):7142-50. PubMed ID: 16239508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis.
    Pujol C; Bliska JB
    Infect Immun; 2003 Oct; 71(10):5892-9. PubMed ID: 14500510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioluminescent tracing of a Yersinia pestis pCD1
    Zhou Y; Zhou J; Ji Y; Li L; Tan Y; Tian G; Yang R; Wang X
    Microbes Infect; 2018 Mar; 20(3):166-175. PubMed ID: 29180033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outer membrane protein A (OmpA) of Yersinia pestis promotes intracellular survival and virulence in mice.
    Bartra SS; Gong X; Lorica CD; Jain C; Nair MK; Schifferli D; Qian L; Li Z; Plano GV; Schesser K
    Microb Pathog; 2012 Jan; 52(1):41-6. PubMed ID: 22023991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia pestis Resists Predation by Acanthamoeba castellanii and Exhibits Prolonged Intracellular Survival.
    Benavides-Montaño JA; Vadyvaloo V
    Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.
    Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK
    Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathionylation of
    Mitchell A; Tam C; Elli D; Charlton T; Osei-Owusu P; Fazlollahi F; Faull KF; Schneewind O
    mBio; 2017 May; 8(3):. PubMed ID: 28512097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioluminescence imaging to track bacterial dissemination of Yersinia pestis using different routes of infection in mice.
    Gonzalez RJ; Weening EH; Frothingham R; Sempowski GD; Miller VL
    BMC Microbiol; 2012 Jul; 12():147. PubMed ID: 22827851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
    Noel BL; Lilo S; Capurso D; Hill J; Bliska JB
    Clin Vaccine Immunol; 2009 Oct; 16(10):1457-66. PubMed ID: 19710295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Inoculation of Mice with Yersinia pestis and Processing of Pulmonary Tissue for Analysis.
    Pechous RD
    Methods Mol Biol; 2019; 2010():17-28. PubMed ID: 31177428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of bubonic plague dynamics by in vivo tracking of bioluminescent Yersinia pestis.
    Nham T; Filali S; Danne C; Derbise A; Carniel E
    PLoS One; 2012; 7(4):e34714. PubMed ID: 22496846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.